Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy. - Wikidata - awgldk - TriplyDB

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy.

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy.

http://www.wikidata.org/entity/Q37986036

about

Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy.A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia.Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP.Therapeutic strategies for tau mediated neurodegeneration.A case of atypical progressive supranuclear palsy.Neuropeptide GPCRs in neuroendocrinology: the case of activity-dependent neuroprotective protein (ADNP)Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid.

P2860

Q28072101-C90E8623-7EE7-4D83-A635-0565E06FE25E Q30540857-503DB8BE-EEA0-45C5-BDCA-1067641F8F9F Q34994716-CAF90689-E643-46E6-AF7A-CDF70546C25A Q36850555-D72700A3-3D59-4225-AAF8-C62ED576390B Q37349806-E4308447-ACF2-4C51-9428-36545B49DD5C Q37550818-3EC5CDAC-6651-4E6D-9094-1FFAAC60ECF8 Q38438828-6308F4C8-2C52-4F58-82F1-5ED342232AA6 Q41110045-C7D0A4AA-B603-4417-B8D1-C2F6EA6314C9 Q48128847-D878A2C7-8EAD-49F4-A393-92B15E728C54

P2860

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy.

http://www.wikidata.org/entity/Q37986036

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Critical appraisal of the role ...... rogressive supranuclear palsy.

@en

Critical appraisal of the role ...... rogressive supranuclear palsy.

@nl

type

label

Critical appraisal of the role ...... rogressive supranuclear palsy.

@en

Critical appraisal of the role ...... rogressive supranuclear palsy.

@nl

prefLabel

Critical appraisal of the role ...... rogressive supranuclear palsy.

@en

Critical appraisal of the role ...... rogressive supranuclear palsy.

@nl

P1433

Q37986036-EE2C03A8-59D7-4716-A879-5DB90A581A59

P1476

Q37986036-991667FB-89B9-42A7-B4DC-EEA2F446337E

P2093

Q37986036-04D8BEA4-095B-4108-9D48-3AD032EC0702

Q37986036-86F5A83B-0456-4470-B734-813265EF0C3C

Q37986036-D3E6C0A9-824B-47AC-B8A5-EC3959BE879B

Q37986036-DA806E1E-7DDC-4123-B997-13191FB9638E

Q37986036-FBF69123-F31D-4EF7-B194-4463FC194AFF

P2860

Q37986036-064E1E92-68DC-4EBD-97ED-010AEC1418EE

Q37986036-097BC771-5231-427A-894E-3B07C71D677D

Q37986036-14EA8CE1-F537-4406-8ABB-DAA0FC90C5AF

Q37986036-18ADC512-CEF2-49D4-8DD8-758B22987E20

Q37986036-19B268B6-67DB-432C-B42F-C407253D54A7

Q37986036-1A0791A0-7B9D-4DBD-B7D9-DAA281218C88

Q37986036-1A20BE21-E761-4030-88B9-AEFF4BEAB030

Q37986036-1B07A688-9738-4674-B5CE-C17042CE54B8

Q37986036-1D892A86-4D33-490C-8276-1C627561AE0F

Q37986036-1EFE2271-47FD-4285-9C8F-F58DA7D4125A

P304

Q37986036-798C2A44-D594-441F-82C6-101C7151DFA6

P31

Q37986036-5C51E8C3-BA97-4820-ACCF-11448AA3E780

P356

Q37986036-731EAF6B-C9E8-46B7-9313-D209B6DFCCA8

P407

Q37986036-B587E713-F98A-40E2-8AED-D01F2E16435C

P478

Q37986036-62AF8C31-3CA8-410D-B44B-77BA322BB2D7

P50

Q37986036-F8F5193B-26F4-41F8-BC0E-5A2F9EE2501F

P577

Q37986036-CAD33CDE-684A-4A9B-96C6-240E0F998C3B

P698

Q37986036-2109831C-BB11-49CB-AAFB-417ACB90F26F

P932

Q37986036-F045902C-0719-4086-8532-5950B646B045

P356

P1433

Neuropsychiatric Disease and Treatment

P1476

Critical appraisal of the role ...... rogressive supranuclear palsy.

@en

P2093

Alistair J Stewart

http://www.w3.org/2001/XMLSchema#string

Bruce H Morimoto

http://www.w3.org/2001/XMLSchema#string

Illana Gozes

http://www.w3.org/2001/XMLSchema#string

Michael Gold

http://www.w3.org/2001/XMLSchema#string

Stefan Lorenzl

http://www.w3.org/2001/XMLSchema#string

P2860

Tubulin seeds alpha-synuclein fibril formation

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study

HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI

Neuropathologic features of amnestic mild cognitive impairment

PolyADP-ribosylation is involved in neurotrophic activity

Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures

Peptide neuroprotection through specific interaction with brain tubulin

Ethanol inhibits neuronal differentiation by disrupting activity-dependent neuroprotective protein signaling

Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis

Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide

P304

85-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NDT.S12518

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

David R. Williams

P577

2012-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22347799

http://www.w3.org/2001/XMLSchema#string

P932

3280109

http://www.w3.org/2001/XMLSchema#string